Page 2 - Nasdaq Tyra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq tyra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Tyra Today - Breaking & Trending Today

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 3.2%

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) shares were down 3.2% during mid-day trading on Monday . The stock traded as low as $14.11 and last traded at $14.69. Approximately 4,929 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 55,555 shares. The stock had previously closed […] ....

Daniel Bensen , Todd Harris , Tyra Biosciences , Geode Capital Management , Vanguard Group Inc , Tyra Biosciences Company Profile , Jpmorgan Chase Co , Blackrock Inc , Tyra Biosciences Inc , Securities Exchange Commission , Get Free Report , Exchange Commission , Capital Management , Tyra Biosciences Daily , Nasdaq Tyra ,

Tyra Biosciences (NASDAQ:TYRA) Shares Up 2.5%

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) shares rose 2.5% during trading on Thursday . The stock traded as high as $15.07 and last traded at $15.01. Approximately 3,254 shares traded hands during trading, a decline of 94% from the average daily volume of 55,580 shares. The stock had previously closed at $14.65. Analyst […] ....

Tyra Biosciences , Todd Harris , Daniel Bensen , Jpmorgan Chase Co , Securities Exchange Commission , Tyra Biosciences Inc , Geode Capital Management , Blackrock Inc , Vanguard Group Inc , Get Free Report , Exchange Commission , Capital Management , Tyra Biosciences Daily , Nasdaq Tyra ,

Tyra Biosciences' (TYRA) Outperform Rating Reiterated at Wedbush

Wedbush reissued their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research note published on Friday, Benzinga reports. The brokerage currently has a $27.00 price objective on the stock. Wedbush also issued estimates for Tyra Biosciences’ Q2 2024 earnings at ($0.38) EPS. Separately, HC Wainwright upped their price objective on […] ....

Tyra Bioscience , Tyra Biosciences , Daniel Bensen , Todd Harris , Allspring Global Investments Holdings , Tyra Biosciences Inc , Barclays Plc , Citigroup Inc , Securities Exchange Commission , Free Report , Exchange Commission , Get Free Report , Tyra Biosciences Daily , Nasdaq Tyra , Reiterated Rating ,

HC Wainwright Boosts Tyra Biosciences (NASDAQ:TYRA) Price Target to $20.00

Tyra Biosciences (NASDAQ:TYRA – Free Report) had its target price boosted by HC Wainwright from $17.00 to $20.00 in a report released on Friday morning, MarketBeat reports. HC Wainwright currently has a buy rating on the stock. Separately, Wedbush initiated coverage on shares of Tyra Biosciences in a research report on Thursday, June 29th. They […] ....

Todd Harris , Tyra Biosciences , Daniel Bensen , Tyra Biosciences Inc , Allspring Global Investments Holdings , Charles Schwab Investment Management Inc , Free Report , Global Investments Holdings , Charles Schwab Investment Management , Schwab Investment Management , Get Free Report , Tyra Biosciences Daily , Nasdaq Tyra , Boost Price Target , Hc Wainwright ,

Tyra Biosciences (NASDAQ:TYRA) Trading 6.4% Higher

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) shares traded up 6.4% during trading on Tuesday . The stock traded as high as $15.06 and last traded at $14.89. 16,430 shares were traded during mid-day trading, a decline of 72% from the average session volume of 58,027 shares. The stock had previously closed at $14.00. […] ....

Todd Harris , Tyra Biosciences , Daniel Bensen , Securities Exchange Commission , Vanguard Group Inc , Tyra Biosciences Inc , Geode Capital Management , Blackrock Inc , Get Free Report , Exchange Commission , Capital Management , Woodline Partners , Tyra Biosciences Daily , Nasdaq Tyra ,